“DNA methylation is an epigenetic mechanism that switches off gene expression. Gene expression regulates cell and tissue function. In this case, the chromosome inherited from the father is always unmethylated and expresses the nc886 gene in all humans,” says Saara Marttila, postdoctoral researcher and first author of the paper.

“The number of individuals whose maternal chromosome is also unmethylated and also expresses RNA appears to be lower in those born into families of highest socio-economic status and in those whose mothers were between 21 and 30 years old,” Marttila says.

The study shows that this early developmentally determined status of DNA methylation in the nc886 gene is stable from childhood to adulthood, throughout a 40-year follow-up. People with both chromosomes unmethylated have twice the amount of nc886 RNA in their blood, and the study also found direct evidence of this at the level of RNA expression over 30 years of follow-up.

“From a molecular biologist’s point of view, this is a beautiful example of epigenetic imprinting,” Marttila and Raitoharju say.

“However, the results also became more interesting from a health perspective when we found that people who also express the nc886 gene from their maternal chromosome – about 25 percent of the population – have higher insulin and lower glucose levels in their adolescence, and men in this group also have higher cholesterol levels,” Raitoharju explains.

The role of a single gene in the whole is small, but in this case the difference in the expression of nc886 is present in all tissues throughout life. The association with glucose and lipid metabolism suggests that this may play a role in an individual’s subsequent risk of disease.

The research group will further investigate the health effects of nc886 gene expression differences in the future.

The data used in the study included, among other things, the follow-up data from the Young Finns Study, which has been running for 40 years, and the corresponding German KORA data.

Source: Eurekalert